Intelligence Platform

Patents

Browse 1,015 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7259278

Anti-S-phase tubulin ligands

Cytoskeleton, Inc. · Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7256004

Variants of humanized anti-carcinoma monoclonal antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7255850

Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-

The Regents of the University of California · Granted Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7250169

Anti-tumor activity of Ea-4-peptide of pro-IGF-1

UNIVERSITY OF CONNECTICUT · Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7205011

Anti-inflammatory activity of a specific turmeric extract

Board of Regents, Acting for and on behalf of, University of Arizona · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System · Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7189393

Recombinant anti-tumor RNAse

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7183388

Anti-MUC-1 single chain antibodies for tumor targeting

The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7141661

Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7129332

Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7118747

AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

Pacific Northwest Biotechnology Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101863

Pharmaceutical compositions with wound healing or anti-complementary activity comprising a

BIODEX · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7101547

Method for the prevention and treatment of diseases caused by an inflammatory response med

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7081518

Anti-mesothelin antibodies having high binding affinity

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7071168

Anti-cancer compounds and methods related thereto

The Regents of the University of Colorado · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7060686

Anti-inflammatory compounds derived from Pseudopterogorgia elisabethae

The Regents of the University of California · Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7052705

Anti-angiogenic peptides

REGENERON PHARMACEUTICALS, INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7025961

Anti-plasmodium composition and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7022720

Synthetic diazonamides as novel anti-mitotic agents

The Board of Regents of the University of Texas System · Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 7019135

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Mar 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6951942

Glucocorticoid-selective anti-inflammatory agents

Ligand Pharmaceuticals Incorporated · Granted Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6916843

Anti-inflammatory actions of cytochrome P450 expoxygenase-derived eicosanoids

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6894149

Anti-HLA-DA antibodies and the methods of using thereof

Protein Design Labs, Inc. · Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6887902

Anti-inflammatory method using gamma-aminobutyric acid (GABA) analogs

The Board of Regents of the University of Texas System · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired